ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The San Francisco-based artificial intelligence startup Yoneda Labs, focused on aiding drug discovery, has raised $4 million in a seed funding round led by Khosla Ventures. The company, founded by researchers from the University of Cambridge, provides software to optimize chemical reactions by determining the best parameters, such as temperature, concentration, and catalysts. The company says the new funds will be used to acquire the robotic automation devices needed to run reactions within Yoneda’s laboratory.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X